Santosh Kottayil
Director/Miembro de la Junta en ACASTI PHARMA INC. .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Santosh Kottayil
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ACASTI PHARMA INC. | Director/Miembro de la Junta | 10/10/2023 | - |
Historial de carrera de Santosh Kottayil
Antiguos cargos conocidos de Santosh Kottayil.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ACASTI PHARMA INC. | Corporate Officer/Principal | - | 08/05/2023 |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Director Ejecutivo | - | 01/08/2021 |
Fundador | - | 01/08/2021 | |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Director Técnico/Científico/I+D | 18/10/2002 | - |
Fundador | 18/10/2002 | - | |
Presidente | 18/10/2002 | - |
Formación de Santosh Kottayil.
University of Kentucky | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sectorial
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Empresas privadas | 2 |
---|---|
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Santosh Kottayil
- Experiencia